LIPOCINE INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIPOCINE INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00.
- LIPOCINE INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $6.99K.
- LIPOCINE INC. stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $0.00.
- LIPOCINE INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $5.34K.
- LIPOCINE INC. stock issued during period, value, stock options exercised for fiscal 2022 was $211.42K, a 3058.87% increase from fiscal 2021.
- LIPOCINE INC. stock issued during period, value, stock options exercised for fiscal 2021 was $6.69K.
- LIPOCINE INC. stock issued during period, value, stock options exercised for fiscal 2019 was $56.20K.
- LIPOCINE INC. stock issued during period, value, stock options exercised for fiscal 2017 was $581.14K, a 4.08% decline from fiscal 2016.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | |
| 2026-03-31 | $6.99K 10-Q · filed 2026-05-07 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $211.42K 10-K · filed 2024-03-07 |
| 2022-09-30 | $5.34K 10-Q · filed 2023-11-08 | $211.42K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $91.00 10-Q · filed 2023-08-10 | $206.08K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $205.99K 10-Q · filed 2023-05-11 | $205.99K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $6.69K 10-K · filed 2023-03-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | |
| 2021-03-31 | $6.69K 10-Q · filed 2022-05-09 | |
| 2020-09-30 | $760.72K 10-Q · filed 2020-11-10 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $56.20K 10-K · filed 2021-03-11 |
| 2019-09-30 | $56.20K 10-Q · filed 2020-11-10 | |
| 2017-12-31 | $581.14K 10-K · filed 2019-03-06 | |
| 2016-12-31 | $605.87K 10-K · filed 2019-03-06 | |
| 2015-12-31 | $276.99K 10-K · filed 2018-03-12 | |
| 2014-12-31 | $56.78K 10-K · filed 2017-03-06 | |
| 2013-12-31 | $10.57K 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |